Vas deferens response to selective opioid receptor agonists in adult mice is impaired following postnatal repeated mild stress

European Journal of Pharmacology

Volumn 458, Issue 1-2, 2003, Pages 201-205

  Loizzo, Alberto ^a   Capasso, Anna ^b   Galietta, Gabriella ^a,b   Severini, Cinzia ^c   Campana, Gabriele ^d   Spampinato, Santi ^d  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antisense oligonucleotide; Ontogenesis; Opioid; Stress; Vas deferens

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE ADRENOCORTICOTROPIN SYNTHESIS INHIBITOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; DERMORPHIN; DYNORPHIN A; HORMONE; HORMONE ANTAGONIST; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR AGONIST; OPIATE AGONIST; SOLVENT; UNCLASSIFIED DRUG;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFICACY; DRUG SELECTIVITY; DRUG SENSITIVITY; HORMONE DETERMINATION; MALE; MOUSE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; SOCIAL ISOLATION; STRESS; VAS DEFERENS; WEANING;

ADRENOCORTICOTROPIC HORMONE; ANALGESICS, OPIOID; ANIMALS; ANIMALS, NEWBORN; DOSE-RESPONSE RELATIONSHIP, DRUG; DYNORPHINS; FEMALE; HUMANS; MALE; MICE; MUTATION; OLIGONUCLEOTIDES, ANTISENSE; OLIGOPEPTIDES; OPIOID PEPTIDES; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; STRESS; TIME FACTORS; VAS DEFERENS;

EID: 12244252747     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02725-5     Document Type: Article

References (18)

1. Anand K.J. Effects of perinatal pain and stress. Prog. Brain Res. 122:2000;117-129.
2. D'Amore A., Mazzucchelli A., Renzi P., Loizzo A. Effect of naloxone on the long-term body weight gain induced by repeated postnatal stress in male mice. Behav. Pharmacol. 7:1996;430-436.
3. D'Arbe M., Chin I., Einstein R., Lavidis N.A. Stress induced changes in transmitter release from sympathetic varicosities of the mouse vas deferens. J. Auton. Nerv. Syst. 76:1999;146-152.
4. De Ceballos M.L., De Felipe C. Circannual variation in opioid receptor sensitivity in mouse vas deferens. Eur. J. Pharmacol. 106:1985;227-228.
5. Goldstein A., James I.F. Site-directed alkylation of multiple opioid receptors: II. Pharmacological selectivity. Mol. Pharmacol. 25:1984;343-348.
6. Goody R.J., Kitchen I. Influence of maternal milk on functional activation of delta-opioid receptors in postnatal rats. J. Pharmacol. Exp. Ther. 296:2001;744-748.
7. Henion P.D., Landis S.C. Developmental regulation of leucine-enkephalin expression in adrenal chromaffin cells by glucocorticoids and innervation. J. Neurosci. 12:1992;3818-3827.
8. Ladd C.O., Huot R.L., Thrivikraman K.V., Nemeroff C.B., Meaney M.J., Plotsky P.M. Long-term behavioural and neuroendocrine adaptation to adverse early experience. Prog. Brain Res. 122:2000;81-103.
9. Loizzo A., Loizzo S., Lopez L., d'Amore A., Renzi P., Spampinato S., Di Carlo S., Bacosi A., Zuccaro P., Pacifici R. Naloxone prevents cell-mediated immune alterations in adult mice following repeated mild stress in the neonatal period. Br. J. Pharmacol. 135:2002;1219-1226.
10. Maldonado R., Severini C., Matthews H.W., Kieffer B.L., Melchiorri P., Negri L. Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene. Br. J. Pharmacol. 132:2001;1485-1492.
11. Negri L., Severini C., Lattanzi R., Potenza R.L., Melchiorri P. Postnatal development of δ-opioid receptor subtypes in mice. Br. J. Pharmacol. 120:1997;989-994.
12. Pieretti S., Di Giannuario A., Domenici M.R., Sagratella S., Capasso A., Sorrentino L., Loizzo A. Dexamethasone-induced selective inhibition of the central mu opioid receptor: functional in vivo and in vitro evidence in rodents. Br. J. Pharmacol. 113:1994;1416-1422.
13. Smith J.A.M., Leslie F.M. Use of organ systems for opioid bioassay. Opioids I. Handb. Exp. Pharmacol. 104/I. 1993;51-78.
14. Spampinato S., Goldstein A. Immunoreactive dynorphin in rat tissues and plasma. Neuropeptides. 3:1983;193-212.
15. Spampinato S., Canossa M., Carboni L., Campana G., Leanza G., Ferri S. Inhibition of proopiomelanocortin expression by an oligodeoxynucleotide complementary to beta endorphin mRNA. Proc. Natl. Acad. Sci. U. S. A. 91:1994;8072-8076.
16. Tallarida R.J., Murray R.B. Manual of Pharmacologic Calculations with Computer Programs. 1986;297 Springer-Verlag, Berlin.
17. Weizman R., Lehmann J., Leschiner S., Allmann I., Stoehr T., Heidbreder C., Domeney A., Feldon J., Gavish M. Long lasting effect of early handling on the peripheral benzodiazepine receptor. Pharmacol. Biochem. Behav. 64:1999;725-729.
18. Wittert G., Hope P., Pyle D. Tissue distribution of opioid receptor gene expression in the rat. Biochem. Biophys. Res. Commun. 218:1996;877-881.